Breakthrough – or even better, revolutionary breakthrough – is perhaps the most overused term in drug development. But the ...

Noul Co. Ltd.’s Micro-Intelligent Laboratory, an artificial intelligence-powered diagnostic system, demonstrated superiority over microscopic diagnosis for malaria in a study presented at the 2024 ...

Biomedicines Inc. and its artificial intelligence platform to generate drugs for multiple undisclosed targets. The number of targets and therapeutic areas also weren’t disclosed. Novartis will pick ...

The U.K. National Institute for Health and Care Excellence reported that mental health professionals experienced a dramatic ...

Chronic pain is taking a significant toll on the mental health and wellbeing of young people across Europe, according to a ...

Both the biotech industry and Hong Kong have become strategic points for China as the People’s Republic of China works to lay ...

Interim phase II data of Wave Life Sciences Ltd.’s oligonucleotide, WVE-N531, revealed “impressive” dystrophin expression, ...

Australia is the skin cancer capital of the world, but with a shortage of dermatologists, patients often wait too long to get ...

Despite a phase IIa failure in 2018 for lupus, Biogen Inc. and UCB Inc. maintained their collaboration and now have new positive data for their anti-CD40L candidate. Top-line phase III data show ...

While in the hot seat at a Sept. 24 U.S. Senate Health, Education, Labor and Pensions (HELP) Committee hearing, Novo Nordisk A/S President and CEO Lars Fruergaard Jørgensen said he would sit down with ...

At the 2024 European College of Neuropsychopharmacology (ECNP) Congress, researchers have presented work that could lead to ways to boost brain development and prevent neurodegeneration in individuals ...

The U.S. FDA’s Oncologic Drugs Advisory Committee (ODAC) on Sept. 26 will take up a controversy that’s hardly new: whether approval of immune checkpoint inhibitor drugs should be restricted in ...